Kolchinsky Peter
Related Filers (70)
- RA CAPITAL MANAGEMENT, L.P. (313)
- RA Capital Healthcare Fund LP (284)
- Shah Rajeev M. (181)
- RA Capital Nexus Fund II, L.P. (53)
- RA Capital Healthcare Fund II, L.P. (42)
- ALDRICH RICHARD (36)
- RA Capital Nexus Fund, L.P. (30)
- Dicerna Pharmaceuticals Inc (23)
- BIOSPECIFICS TECHNOLOGIES CORP (21)
- ACHILLION PHARMACEUTICALS INC (19)
- Wave Life Sciences Ltd. (16)
- SEQUENOM INC (13)
- 89bio, Inc. (12)
- SANGAMO BIOSCIENCES INC (10)
- Aclaris Therapeutics, Inc. (10)
- Ra Pharmaceuticals, Inc. (9)
- Cytek Biosciences, Inc. (9)
- ARADIGM CORP (8)
- Solid Biosciences Inc. (8)
- Enliven Therapeutics, Inc. (8)
- Kala Pharmaceuticals, Inc. (7)
- Forma Therapeutics Holdings, Inc. (7)
- Satsuma Pharmaceuticals, Inc. (7)
- DICE Therapeutics, Inc. (7)
- AN2 Therapeutics, Inc. (7)
- Nkarta, Inc. (6)
- Vor Biopharma Inc. (6)
- Werewolf Therapeutics, Inc. (6)
- PepGen Inc. (6)
- Fulcrum Therapeutics, Inc. (6)
- LIPID SCIENCES INC/ (5)
- KalVista Pharmaceuticals, Inc. (5)
- Synthorx, Inc. (5)
- Phathom Pharmaceuticals, Inc. (5)
- Acumen Pharmaceuticals, Inc. (5)
- Icosavax, Inc. (5)
- Eliem Therapeutics, Inc. (5)
- Janux Therapeutics, Inc. (5)
- Tyra Biosciences, Inc. (5)
- ARS Pharmaceuticals, Inc. (5)
- scPharmaceuticals Inc. (4)
- RHYTHM PHARMACEUTICALS, INC. (4)
- iTeos Therapeutics, Inc. (4)
- Aerovate Therapeutics, Inc. (4)
- Mineralys Therapeutics, Inc. (4)
- RA Capital Nexus Fund III, L.P. (4)
- CURIS INC (3)
- DERMA SCIENCES, INC. (3)
- Verastem, Inc. (3)
- Therapeutics Acquisition Corp. (3)
- Vaxcyte, Inc. (3)
- Orchard Therapeutics plc (3)
- Acrivon Therapeutics, Inc. (3)
- G1 Therapeutics, Inc. (2)
- Eidos Therapeutics, Inc. (2)
- ARVINAS INC. (2)
- Akouos, Inc. (2)
- Pandion Therapeutics, Inc. (2)
- Inozyme Pharma, Inc. (2)
- Inhibrx, Inc. (2)
- TG THERAPEUTICS, INC. (2)
- Dyne Therapeutics, Inc. (2)
- PMV Pharmaceuticals, Inc. (2)
- Iterum Therapeutics plc (2)
- Eiger BioPharmaceuticals, Inc. (1)
- Cardiff Oncology, Inc. (1)
- MIRAGEN THERAPEUTICS, INC. (1)
- Research Alliance Corp. II (1)
- RxSight, Inc. (1)
- Black Diamond Therapeutics, Inc. (1)
- Show More ...
Ownership (349)
4
Wednesday, 2/14/2024
Mineralys Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/13/2024
PepGen Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/8/2024
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4/A
Wednesday, 1/17/2024
Wave Life Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Friday, 1/12/2024
Solid Biosciences Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/13/2023
89bio, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/13/2023
Wave Life Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Monday, 9/25/2023
ARS Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 8/31/2023
ARS Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/22/2023
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/9/2023
DICE Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/9/2023
Wave Life Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/25/2023
Acumen Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/21/2023
Janux Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/7/2023
Black Diamond Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/28/2023
ARS Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/23/2023
Werewolf Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/16/2023
Janux Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/13/2023
Acumen Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/12/2023
Satsuma Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/9/2023
Nkarta, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/8/2023
Aerovate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/8/2023
Icosavax, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/8/2023
Solid Biosciences Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/2/2023
Vor Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/2/2023
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/22/2023
Eliem Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/30/2023
DICE Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/30/2023
89bio, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 3/27/2023
DICE Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/27/2023
Enliven Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/16/2023
Mineralys Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/13/2023
Mineralys Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 2/9/2023
Mineralys Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 1/24/2023
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/10/2023
Werewolf Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/6/2023
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 1/5/2023
IMARA Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/29/2022
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/21/2022
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/16/2022
Fulcrum Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/15/2022
Solid Biosciences Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 12/12/2022
IMARA Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/9/2022
Vor Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 12/5/2022
Solid Biosciences Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/21/2022
Acrivon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/16/2022
Acrivon Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 11/10/2022
ARS Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 11/10/2022
ARS Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 11/9/2022
Acrivon Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 10/24/2022
IMARA Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/20/2022
89bio, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/19/2022
IMARA Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/19/2022
IMARA Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 10/19/2022
DICE Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/14/2022
Forma Therapeutics Holdings, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 8/26/2022
Fulcrum Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 8/17/2022
Wave Life Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Friday, 8/5/2022
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/28/2022
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/6/2022
89bio, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/23/2022
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/22/2022
Aerovate Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/21/2022
Wave Life Sciences Ltd.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/21/2022
Acumen Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/17/2022
Vor Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/16/2022
Janux Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/15/2022
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/15/2022
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/14/2022
Icosavax, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/10/2022
Nkarta, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/10/2022
iTeos Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/9/2022
Solid Biosciences Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/9/2022
Forma Therapeutics Holdings, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/8/2022
DICE Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/7/2022
Satsuma Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/3/2022
Werewolf Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/2/2022
89bio, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/1/2022
Eliem Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 5/26/2022
Kala Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/25/2022
Kala Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3/A
Thursday, 5/12/2022
PepGen Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 5/12/2022
PepGen Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/10/2022
PepGen Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 5/5/2022
PepGen Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 4/28/2022
Nkarta, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/31/2022
AN2 Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/30/2022
Icosavax, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 3/24/2022
AN2 Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 3/16/2022
Cytek Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/11/2022
Cytek Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/8/2022
Cytek Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/2/2022
Cytek Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/25/2022
Cytek Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/22/2022
Cytek Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/16/2022
Cytek Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 9/20/2021
DICE Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/17/2021
Tyra Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Tuesday, 9/14/2021
Tyra Biosciences, Inc.: Initial statement of beneficial ownership of securities
3
Tuesday, 9/14/2021
DICE Therapeutics, Inc.: Initial statement of beneficial ownership of securities